Recombinant Human DNASE1L3 Protein，His

DNASE1L3, a member of the DNase I family, has gained significant attention in recent years due to its crucial role in extracellular DNA degradation and its potential implications in various biological processes and diseases. This enzyme is predominantly expressed in tissues such as the pancreas, lung, and spleen, where it participates in clearing excess DNA from the extracellular environment, thus preventing detrimental inflammatory responses. The dysfunction of DNASE1L3 has been linked to several pathological conditions, including autoimmune diseases and chronic inflammatory disorders, highlighting its importance in maintaining cellular homeostasis and immune regulation. The recombinant expression of DNASE1L3 allows researchers to study its enzymatic properties, structure-function relationship, and therapeutic potential in greater detail. Understanding the biochemical and biophysical characteristics of DNASE1L3 could pave the way for the development of novel therapeutic strategies aimed at modulating extracellular DNA levels, enhancing the immune response, or even treating diseases associated with dysregulated DNA clearance. The use of recombinant protein also facilitates the exploration of DNASE1L3's interactions with other biomolecules, potentially shedding light on its role in disease processes and offering insights into novel diagnostic and therapeutic applications. Overall, ongoing research into DNASE1L3 holds promise for addressing significant medical challenges and advancing our comprehension of fundamental biological mechanisms.